132 related articles for article (PubMed ID: 11316375)
21. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
Lee JD; Friedmann PD; Kinlock TW; Nunes EV; Boney TY; Hoskinson RA; Wilson D; McDonald R; Rotrosen J; Gourevitch MN; Gordon M; Fishman M; Chen DT; Bonnie RJ; Cornish JW; Murphy SM; O'Brien CP
N Engl J Med; 2016 Mar; 374(13):1232-42. PubMed ID: 27028913
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
[TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
[TBL] [Abstract][Full Text] [Related]
24. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.
Ahmadi J; Kampman KM; Oslin DM; Pettinati HM; Dackis C; Sparkman T
Am J Addict; 2009; 18(1):81-6. PubMed ID: 19219669
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial.
Jones HE; Johnson RE; Bigelow GE; Silverman K; Mudric T; Strain EC
Am J Addict; 2004; 13(5):421-37. PubMed ID: 15764421
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
[TBL] [Abstract][Full Text] [Related]
27. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
[TBL] [Abstract][Full Text] [Related]
28. Randomized trial of continuing care enhancements for cocaine-dependent patients following initial engagement.
McKay JR; Lynch KG; Coviello D; Morrison R; Cary MS; Skalina L; Plebani J
J Consult Clin Psychol; 2010 Feb; 78(1):111-20. PubMed ID: 20099956
[TBL] [Abstract][Full Text] [Related]
29. Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial.
Mooney ME; Schmitz JM; Allen S; Grabowski J; Pentel P; Oliver A; Hatsukami DK
Clin Pharmacol Ther; 2016 Oct; 100(4):344-52. PubMed ID: 27213949
[TBL] [Abstract][Full Text] [Related]
30. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects.
Carroll KM; Rounsaville BJ; Nich C; Gordon LT; Wirtz PW; Gawin F
Arch Gen Psychiatry; 1994 Dec; 51(12):989-97. PubMed ID: 7979888
[TBL] [Abstract][Full Text] [Related]
31. A placebo-controlled screening trial of celecoxib for the treatment of cocaine dependence.
Reid MS; Angrist B; Baker S; Woo C; Schwartz M; Montgomery A; Majewska D; Robinson J; Rotrosen J
Addiction; 2005 Mar; 100 Suppl 1():32-42. PubMed ID: 15730348
[TBL] [Abstract][Full Text] [Related]
32. Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial.
Lee JD; McDonald R; Grossman E; McNeely J; Laska E; Rotrosen J; Gourevitch MN
Addiction; 2015 Jun; 110(6):1008-14. PubMed ID: 25703440
[TBL] [Abstract][Full Text] [Related]
33. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.
Petrakis IL; O'Malley S; Rounsaville B; Poling J; McHugh-Strong C; Krystal JH;
Psychopharmacology (Berl); 2004 Mar; 172(3):291-7. PubMed ID: 14634716
[TBL] [Abstract][Full Text] [Related]
34. Effects of naltrexone on cue-elicited craving for alcohol and cocaine.
Modesto-Lowe V; Burleson JA; Hersh D; Bauer LO; Kranzler HR
Drug Alcohol Depend; 1997 Dec; 49(1):9-16. PubMed ID: 9476694
[TBL] [Abstract][Full Text] [Related]
35. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
[TBL] [Abstract][Full Text] [Related]
36. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.
Bisaga A; Sullivan MA; Glass A; Mishlen K; Pavlicova M; Haney M; Raby WN; Levin FR; Carpenter KM; Mariani JJ; Nunes EV
Drug Alcohol Depend; 2015 Sep; 154():38-45. PubMed ID: 26187456
[TBL] [Abstract][Full Text] [Related]
37. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
[TBL] [Abstract][Full Text] [Related]
38. [Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial].
Krupitskiĭ EM; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Blokhina EA; Silverman BL
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5 Pt 2):3-11. PubMed ID: 22951790
[TBL] [Abstract][Full Text] [Related]
39. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
Dackis CA; Kampman KM; Lynch KG; Pettinati HM; O'Brien CP
Neuropsychopharmacology; 2005 Jan; 30(1):205-11. PubMed ID: 15525998
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic treatments for heroin and cocaine dependence.
Kleber HD
Am J Addict; 2003; 12(s2):S5-S18. PubMed ID: 12857659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
